Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Clinical Follow-up Study to Assess the Safety, Performance, and Clinical Benefit of the CE-marked Drainova® ArgentiC Catheter

NCT06436807 is registered in ClinicalTrials.gov with ewimed GmbH as lead sponsor.

NCT NCT06436807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06436807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Clinical Follow-up Study to Assess the Safety, Performance, and Clinical Benefit of the CE-marked Drainova® ArgentiC Catheter
Lead sponsor
ewimed GmbH
Phase
Observational
Overall status
Completed
Start date
June 26, 2024
Completion date
January 9, 2026
Enrollment
169 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

ascites, ascites, malignant, pleural effusion, pleural effusion, malignant